<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04880954</url>
  </required_header>
  <id_info>
    <org_study_id>#21-NPI-101</org_study_id>
    <nct_id>NCT04880954</nct_id>
  </id_info>
  <brief_title>Manual Therapy and Rehabilitation on Pain and Physical Functioning for Chronic Knee Pain</brief_title>
  <official_title>Soft Tissue Mobilization and Rehabilitation on Pain and Physical Functioning for Non-Specific Chronic Knee Pain: A Randomized Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neuro Performance Integration</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Neuro Performance Integration</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study examining if hands-on therapy and prescribed exercise is an&#xD;
      effective way to manage and reduce knee pain. It will also look at physical benefits of this&#xD;
      treatment including balance, strength, and flexibility.&#xD;
&#xD;
      Participation will include 2 assessment days and a 12-week treatment cycle. Assessments will&#xD;
      be conducted during week 1 and after treatment. The treatment will vary based on the assigned&#xD;
      group. This may include 12 in-person manual therapy sessions occurring once per week and or&#xD;
      12-weeks of at-home therapy occurring 5 times per week.&#xD;
&#xD;
      The greatest risk of participation includes possible muscle/joint soreness, injury during&#xD;
      at-home exercises, and loss of confidentiality.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 31, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 23, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants will be randomly assigned to one of three groups 1) Manual Therapy, 2) Rehabilitation, or 3) Combination of both</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Participants will know the group they are randomly assigned.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Perceived Pain</measure>
    <time_frame>This will be measured pre- and post- intervention (week 1 and week 13).</time_frame>
    <description>The Visual Analogue Scale (VAS) will be used to quantify pain. The scale ranges from 1 (no pain) to 10 (worst pain).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Range of Motion</measure>
    <time_frame>This will be measured pre- and post- intervention (week 1 and week 13)</time_frame>
    <description>A goniometer will be used to assess range of motion of the hip and knee.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Clinical Test of Sensory Integration and Balance</measure>
    <time_frame>This will be measured pre- and post- intervention (week 1 and week 13).</time_frame>
    <description>The Balance Tracking System will be used to assess balance.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isometric Strength</measure>
    <time_frame>This will be measured pre- and post- intervention (week 1 and week 13).</time_frame>
    <description>A crane scale will be used to measure changes in isometric strength (pounds). The hamstring and quadricep will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Limits of Stability</measure>
    <time_frame>This will be measured pre- and post- intervention (week 1 and week 13).</time_frame>
    <description>The Balance Tracking System will be used to assess limits of stability.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Non-Specific Chronic Knee Pain</condition>
  <arm_group>
    <arm_group_label>Soft Tissue Mobilization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Soft Tissue Mobilization and Rehabiliation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Soft Tissue Mobilization</intervention_name>
    <description>Soft Tissue Mobilization will be provided to participants by Licensed Chiropractor focusing on structures of the lower and upper leg. This will be provided for 20 minutes, once per week for 12 weeks.</description>
    <arm_group_label>Soft Tissue Mobilization</arm_group_label>
    <arm_group_label>Soft Tissue Mobilization and Rehabiliation</arm_group_label>
    <other_name>Manual Therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Rehabilitation</intervention_name>
    <description>Participants will engage in 20 minutes of prescribed at-home exercise 5 times per week, for 12 weeks.</description>
    <arm_group_label>Rehabilitation</arm_group_label>
    <arm_group_label>Soft Tissue Mobilization and Rehabiliation</arm_group_label>
    <other_name>Injury Prevention Therapy</other_name>
    <other_name>Isometric Exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults experiencing non-specific knee pain for 3 or more months. Pain must be 3/10&#xD;
             (VAS) or higher.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pain due to knee surgery, fracture, tumor, trauma, or those on medication for mood&#xD;
             disorder (assessed on case by case basis).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beverly Albert, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neuro Performance Integration</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beverly Albert, MS</last_name>
    <phone>435-640-0429</phone>
    <email>beverlyalbert@npipc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neuro Performance Integration</name>
      <address>
        <city>Park City</city>
        <state>Utah</state>
        <zip>84060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jake Shores, DC</last_name>
      <phone>435-640-0429</phone>
      <email>drshores@npipc.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 3, 2021</study_first_submitted>
  <study_first_submitted_qc>May 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 11, 2021</study_first_posted>
  <last_update_submitted>July 14, 2021</last_update_submitted>
  <last_update_submitted_qc>July 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Neuro Performance Integration</investigator_affiliation>
    <investigator_full_name>Beverly Albert</investigator_full_name>
    <investigator_title>Research Director</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

